We strive to serve all our clients in an optimal way. Our global locations and expansion strategy ensures that we’re located near to our clients.
Batavia Biosciences was fully operational in Leiden, the Netherlands in January 2010. In 2012 we launched our US subsidiary in Woburn, MA. In 2015 the company opened an office in Hong Kong to serve the growing order portfolio in Asia
In Woburn and Leiden, Batavia Biosciences currently occupies 37,500 ft2 of BSL-2 and BSL-2+ R&D facilities with dedicated mammalian and microbial vaccine and protein suites up to 100 L production capacity.
Batavia Biosciences also offers a fully equipped BSL-2 GMP facility up to 200 L scale.